Fortress Biotech Q3 Revenue Rises 9% to $19.2 Million; Reports $7.9 Million Loss

Fortress Biotech reported third-quarter 2026 net revenue of $19.2 million, up approximately 9% from a year earlier, and a net loss attributable to common stockholders of $7.9 million. The company ended the quarter with $152.2 million in consolidated cash and cash equivalents and said it repaid its…